GlassScriptPhysician profile
Paul Porter
NPI 1114284536
$5,751.35
in general payments reported to CMS, 2019-2025
24 companies · $1,261 in 2025
The $1,261 reported for 2025 was more than what 84% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.56 · 2020: $300 · 2021: $516 · 2022: $428 · 2023: $867 · 2024: $2,287 · 2025: $1,261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,482 · Travel and Lodging: $933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,481.74 |
| Travel and Lodging | $932.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $4,418.52 | 2020-2025 | Inspire |
| Genzyme Corporation | $364.18 | 2019-2025 | |
| Stryker Corporation | $183.17 | 2019-2020 | |
| Aerin Medical INC. | $99.19 | 2024-2025 | |
| Integra Lifesciences Corporation | $83.68 | 2024 | Trudi Probe, Inspira Air, Acclarent Aera |
| Regeneron Healthcare Solutions, INC. | $72.70 | 2022-2025 | Dupixent |
| Optinose US, INC. | $72.61 | 2019-2023 | |
| Acclarent, INC | $64.09 | 2023 | Relieva Spinplus, Acclarent Aera |
| Alk-Abello, INC | $44.72 | 2019-2024 | Pre-Pen, Standardized Mite D. Farinae, Alternaria Tenuis |
| Glaxosmithkline, LLC. | $40.43 | 2022 | |
| Phadia US INC. | $39.24 | 2023 | Immunocap |
| Baxter Healthcare | $37.68 | 2022 | |
| Merck Sharp & Dohme LLC | $33.68 | 2021-2023 | |
| Pharming Healthcare, INC. | $27.90 | 2022 | |
| Kaleo, INC. | $24.20 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Checkpoint Surgical, INC | $20.41 | 2021 | |
| Medtronic, INC. | $18.68 | 2024 | Ligasure |
| Phathom Pharmaceuticals, INC. | $17.59 | 2024 | Voquezna |
| Olympus America INC. | $17.58 | 2023 | |
| Zimmer Biomet Holdings, INC. | $16.32 | 2025 | Walterlorenz Surgical Assist Arm |
| Hologic Sales and Service, LLC | $16.18 | 2022 | |
| Amgen INC. | $13.66 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.12 | 2022 | |
| Cook Medical LLC | $11.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Porter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.